APO2L/TRAIL expression in human brain tumors
β Scribed by M. Nakamura; J. Rieger; M. Weller; J. Kim; P. Kleihues; H. Ohgaki
- Publisher
- Springer-Verlag
- Year
- 2000
- Tongue
- English
- Weight
- 334 KB
- Volume
- 99
- Category
- Article
- ISSN
- 0001-6322
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Members of the tumor necrosis factor (TNF) family such as CD95 (APO-1/Fas) ligand (L) trigger apoptosis in lymphoid cells. Recently, a new member of apoptosis-inducing ligands, TRAIL (TNF-related-apoptosis-inducing-ligand)/Apo-2 ligand, was identified that might act in a similar way. We compared TRA
## Abstract Matrix metalloproteinases (MMP) which degrades protein components of the extraβcellular matrix and basement membrane seems to be largely involved in cancer invasiveness. MMP proteolitic activity essentially comes from stromal cells but matrilysin (MMPβ7) is produced by the tumor itself.